[ad_1]
The Trump administration is considering fast-tracking an experimental Covid-19 vaccine being developed by AstraZeneca Plc and Oxford University to be used within the US forward of the November three elections, the Financial Times reported.
One possibility being explored would contain the US Food and Drug Administration (FDA) awarding “emergency use authorization” in October to the potential vaccine, which was developed by Oxford and licensed to AstraZeneca, the FT reported.
[ad_2]
Source hyperlink